Homocystinuria Market on Track for Major Expansion by 2032, According to DelveInsight | Orphan Technologies, Travere Therapeutics, Synlogic

DelveInsight's "Homocystinuria Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Homocystinuria, historical and forecasted epidemiology as well as the Homocystinuria market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Homocystinuria market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Homocystinuria Market Forecast
https://www.delveinsight.com/sample-request/homocystinuria-market-new?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Homocystinuria Market Report:
• The Homocystinuria market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• Nearly 45,000 cases of Homocystinuria were reported to be widespread overall in the 7MM in 2022, according to DelveInsight data
• In the US, 14,000 cases of Homocystinuria were detected overall in 2022. The number of these cases is expected to rise between 2019 and 2032.
• Germany had the most total and frequent Homocystinuria cases among the EU4 and the UK in 2022, while Spain had the fewest cases.
• In May 2023, Travere Therapeutics announced positive results from cohort 6 in the placebo-controlled Phase I/IICOMPOSE Study of pegtibatinase, a novel investigational enzyme replacement therapy being evaluated for the treatment of classical homocystinuria (HCU). Till date,pegtibatinase has been generally well-tolerated.
• Males and females are equally affected by homocystinuria owing to CBS deficiency, which is classified as an uncommon disorder by the National Organization for uncommon Disorders (NORD). According to population surveys, 1 in 344,000 people worldwide are thought to have homocystinuria. According to estimates, the prevalence in Germany is 1 in 17,500 cases
• The age group of 55-74 years old had the highest age-specific prevalence cases
• Key Homocystinuria Companies: Orphan Technologies, Travere Therapeutics, Synlogic, and others
• Key Homocystinuria Therapies: Pegtibatinase(TVT-058), SYNB1353, and others
• The Homocystinuria market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Homocystinuria pipeline products will significantly revolutionize the Homocystinuria market dynamics.

Homocystinuria Overview
Homocystinuria is a rare, inherited metabolic disorder characterized by an accumulation of homocysteine, an amino acid, in the blood and urine. It is caused by a deficiency in one of several enzymes responsible for processing homocysteine, leading to elevated levels and a range of potential health problems.

Get a Free sample for the Homocystinuria Market Report
https://www.delveinsight.com/report-store/homocystinuria-market-new?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Homocystinuria Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Homocystinuria Epidemiology Segmentation:
The Homocystinuria market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Homocystinuria
• Prevalent Cases of Homocystinuria by severity
• Gender-specific Prevalence of Homocystinuria
• Diagnosed Cases of Episodic and Chronic Homocystinuria

Download the report to understand which factors are driving Homocystinuria epidemiology trends @ Homocystinuria Epidemiology Forecast
https://www.delveinsight.com/sample-request/homocystinuria-market-new?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Homocystinuria Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Homocystinuria market or expected to get launched during the study period. The analysis covers Homocystinuria market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Homocystinuria Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Homocystinuria Therapies and Key Companies
• Pegtibatinase(TVT-058): Orphan Technologies/TravereTherapeutics
• SYNB1353: Synlogic

Discover more about therapies set to grab major Homocystinuria market share @ Homocystinuria Treatment Market
https://www.delveinsight.com/sample-request/homocystinuria-market-new?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Homocystinuria Market Strengths
• Improvement in diagnostic procedures like, New Born Screening Systems, has been a major factor in making the diagnosis of HCU much less complicated. Along with detecting elevated methionine (Met) level, analysis of total homocysteine (tHcy) as a second tier marker and calculating the Met/tHcy ratio is also recommended bylatest guidelines and this might leads to increase in diagnosis of HCU

Homocystinuria Market Opportunities
• The strong clinical development of novel therapeutics will have a positive effect on the market. Most of the groups and companies involved in research related to homocystinuria are also working towards improving the current diagnosis rate as well and this will provide the larger windows of opportunity for emerging therapies.

Scope of the Homocystinuria Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Homocystinuria Companies: Orphan Technologies, TravereTherapeutics, Synlogic, and others
• Key Homocystinuria Therapies: Pegtibatinase(TVT-058), SYNB1353, and others
• Homocystinuria Therapeutic Assessment: Homocystinuria current marketed and Homocystinuria emerging therapies
• Homocystinuria Market Dynamics: Homocystinuria market drivers and Homocystinuria market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Homocystinuria Unmet Needs, KOL's views, Analyst's views, Homocystinuria Market Access and Reimbursement

To know more about Homocystinuria companies working in the treatment market, visit @ Homocystinuria Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/homocystinuria-market-new?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Homocystinuria Market Report Introduction
2. Executive Summary for Homocystinuria
3. SWOT analysis of Homocystinuria
4. Homocystinuria Patient Share (%) Overview at a Glance
5. Homocystinuria Market Overview at a Glance
6. Homocystinuria Disease Background and Overview
7. Homocystinuria Epidemiology and Patient Population
8. Country-Specific Patient Population of Homocystinuria
9. Homocystinuria Current Treatment and Medical Practices
10. Homocystinuria Unmet Needs
11. Homocystinuria Emerging Therapies
12. Homocystinuria Market Outlook
13. Country-Wise Homocystinuria Market Analysis (2019-2032)
14. Homocystinuria Market Access and Reimbursement of Therapies
15. Homocystinuria Market Drivers
16. Homocystinuria Market Barriers
17. Homocystinuria Appendix
18. Homocystinuria Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:

Homocystinuria Pipeline https://www.delveinsight.com/report-store/homocystinuria-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Homocystinuria Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Homocystinuria market. A detailed picture of the Homocystinuria pipeline landscape is provided, which includes the disease overview and Homocystinuria treatment guidelines.

Homocystinuria Epidemiology https://www.delveinsight.com/report-store/homocystinuria-epidemiology-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Homocystinuria Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Homocystinuria epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports by DelveInsight

Idiopathic Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/idiopathic-thrombocytopenic-purpura-market
DelveInsight's "Idiopathic Thrombocytopenic Purpura Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Idiopathic Thrombocytopenic Purpura, historical and forecasted epidemiology as well as the Idiopathic Thrombocytopenic Purpura market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Inguinal Hernia Market
https://www.delveinsight.com/report-store/inguinal-hernia-market
DelveInsight's "Inguinal Hernia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Inguinal Hernia, historical and forecasted epidemiology as well as the Inguinal Hernia market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Charcot-marie-tooth Disease Market
https://www.delveinsight.com/report-store/charcot-marie-tooth-disease-market
DelveInsight's 'Charcot-Marie-Tooth Disease Market Insights, Epidemiology, and Market Forecast 2032' report deliver an in-depth understanding of the Charcot-Marie-Tooth Disease, historical and forecasted epidemiology as well as the Charcot-Marie-Tooth Disease market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.

Listeriosis Market
https://www.delveinsight.com/report-store/listeriosis-market
DelveInsight's comprehensive report titled "Listeriosis Market Insights, Epidemiology, and Market Forecast - 2034" offers a detailed analysis of Listeriosis. The report presents historical and projected epidemiological data covering incident cases of listeriosis, age-specific cases of listeriosis, gender-specific cases of listeriosis, risk-associated cases of listeriosis, and treated cases of listeriosis.

Dysfunctional Uterine Bleeding Market
https://www.delveinsight.com/report-store/dysfunctional-uterine-bleeding-market
DelveInsight's "Dysfunctional Uterine Bleeding Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Dysfunctional Uterine Bleeding, historical and forecasted epidemiology as well as the Dysfunctional Uterine Bleeding market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Mrna Based Vaccines And Therapeutics Market
https://www.delveinsight.com/report-store/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market
DelveInsight's "Global Messenger RNA (mRNA)-based Vaccines and Therapeutics- Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Global Messenger RNA (mRNA)-based Vaccines and Therapeutics, historical and forecasted epidemiology as well as the Global Messenger RNA (mRNA)-based Vaccines and Therapeutics market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Papilloma Market
https://www.delveinsight.com/report-store/papilloma-market
DelveInsight's "Papilloma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Papilloma, historical and forecasted epidemiology as well as the Papilloma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Periodontal Disease Market
https://www.delveinsight.com/report-store/periodontal-disease-market
DelveInsight's "Periodontal Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Periodontal Disease, historical and forecasted epidemiology as well as the Periodontal Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.